‘ORACLE’ lung cancer test shows promise for predicting survival with superior precision

A team of UK investigators have been examining a lung cancer tissue biopsy test that they say can predict a patient’s chances of survival with better accuracy than other diagnostics measures. It identifies the disease in its early stages, determining whether it is likely to spread and if chemotherapy drugs will be effective.

These researchers from the University College London Cancer Centre and The Francis Crick Institute published an extensive study on the “ORACLE” test in Nature…